Characterization of exosomal RNAs derived from human gastric cancer cells by deep sequencing

Exosomes secreted from the cell to the extracellular environment play an important role in intercellular communication. Next-generation sequencing technology, which has achieved great development recently, allows us to detect more complete data and gain even deeper analyses of RNA transcriptomes. In our research, we extracted exosomes from different gastric cancer cell lines and immortalized normal gastric mucosal epithelial cell line and examined the amounts of exosomal proteins and RNAs. Our data showed that the secreted amount of cancer cell–derived exosomes, which contain proteins and RNAs, was much higher than that of normal cell–derived exosomes. Moreover, next-generation sequencing technology confirmed the presence of small non-coding RNAs in exosomes. Based on publicly available databases, we classified small non-coding RNAs. According to the microRNA profiles of exosomes, hsa-miR-21-5p and hsa-miR-30a-5p were two of the most abundant sequences among all libraries. The expression levels of the two microRNAs, miR-100 and miR-148a, in exosomes were validated through reverse transcription polymerase chain reaction. The reverse transcription polymerase chain reaction result, consistent with the trend of sequencing result, indicated a significant difference in exosomes between gastric cancer and gastric mucosal epithelial cell lines. We also predicted novel microRNA candidates but they need to be validated. This research provided an atlas of small non-coding RNA in exosomes and may make a little contribution to the understanding of exosomal RNA composition and finding parts of differential expression of RNAs in exosomes.

[1]  M. Amiji,et al.  Pancreatic Cancer Cell Exosome-Mediated Macrophage Reprogramming and the Role of MicroRNAs 155 and 125b2 Transfection using Nanoparticle Delivery Systems , 2016, Scientific Reports.

[2]  Z. Pan,et al.  Exosomes derived from gastric cancer cells activate NF-κB pathway in macrophages to promote cancer progression , 2016, Tumor Biology.

[3]  M. Odenthal,et al.  Serum microRNA profiles as prognostic or predictive markers in the multimodality treatment of patients with gastric cancer. , 2015, Oncology letters.

[4]  Y. Liu,et al.  Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma. , 2015, Oncology reports.

[5]  George C. Mayne,et al.  Circulating Serum Exosomal miRNAs As Potential Biomarkers for Esophageal Adenocarcinoma , 2015, Journal of Gastrointestinal Surgery.

[6]  R. Chen,et al.  Circulating MicroRNA-21 Is a Potential Diagnostic Biomarker in Gastric Cancer , 2015, Disease markers.

[7]  H. Yao,et al.  MicroRNA100 inhibits self-renewal of breast cancer stem-like cells and breast tumor development. , 2014, Cancer research.

[8]  G. Calin,et al.  Exosomes as divine messengers: are they the Hermes of modern molecular oncology? , 2014, Cell Death and Differentiation.

[9]  Zhenggang Zhu,et al.  Prognostic Role of MicroRNA-21 in Gastric Cancer: A Meta-Analysis , 2014, Medical science monitor : international medical journal of experimental and clinical research.

[10]  S. Zhuang,et al.  MicroRNA-148a suppresses the epithelial–mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling , 2014, Oncogene.

[11]  X Wang,et al.  MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin , 2014, Oncogene.

[12]  W. Kuo,et al.  miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/β-catenin/BCL9 pathway. , 2014, Cancer research.

[13]  Ying Zhang,et al.  microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma. , 2014, Cancer research.

[14]  Peijing Zhang,et al.  miR-100 Induces Epithelial-Mesenchymal Transition but Suppresses Tumorigenesis, Migration and Invasion , 2014, PLoS genetics.

[15]  Jiping Zeng,et al.  RUNX3 regulates vimentin expression via miR-30a during epithelial–mesenchymal transition in gastric cancer cells , 2014, Journal of cellular and molecular medicine.

[16]  W. Jiang,et al.  Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes , 2014, Oncogene.

[17]  Marta Di Nicola,et al.  microRNAs Derived from Circulating Exosomes as Noninvasive Biomarkers for Screening and Diagnosing Lung Cancer , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[18]  T. Shibata,et al.  miR‐148a plays a pivotal role in the liver by promoting the hepatospecific phenotype and suppressing the invasiveness of transformed cells , 2013, Hepatology.

[19]  C. Gebeshuber,et al.  miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling , 2013, Oncogene.

[20]  R. Setterquist,et al.  Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. , 2012, Biochimica et biophysica acta.

[21]  H. Adomat,et al.  Exosomes as Biomarker Enriched Microvesicles: Characterization of Exosomal Proteins Derived from a Panel of Prostate Cell Lines with Distinct AR Phenotypes , 2012, Molecular & Cellular Proteomics.

[22]  H. Allgayer,et al.  MicroRNA‐30a inhibits epithelial‐to‐mesenchymal transition by targeting Snai1 and is downregulated in non‐small cell lung cancer , 2012, International journal of cancer.

[23]  M. Lotze,et al.  microRNA 30A promotes autophagy in response to cancer therapy , 2012, Autophagy.

[24]  Chun-Wen Cheng,et al.  MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer , 2012, Breast Cancer Research and Treatment.

[25]  K. Birkenkamp-Demtroder,et al.  MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL. , 2012, Carcinogenesis.

[26]  Zhenggang Zhu,et al.  microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN , 2012, Oncology reports.

[27]  Richard J. Simpson,et al.  ExoCarta as a resource for exosomal research , 2012, Journal of extracellular vesicles.

[28]  Xianghuo He,et al.  MicroRNA-148a Suppresses Tumor Cell Invasion and Metastasis by Downregulating ROCK1 in Gastric Cancer , 2011, Clinical Cancer Research.

[29]  M. Lai,et al.  MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer , 2011, Cell Death and Differentiation.

[30]  J. Sluijter,et al.  MicroRNA-100 Regulates Neovascularization by Suppression of Mammalian Target of Rapamycin in Endothelial and Vascular Smooth Muscle Cells , 2011, Circulation.

[31]  Aled Clayton,et al.  Cancer exosomes trigger fibroblast to myofibroblast differentiation. , 2010, Cancer research.

[32]  S. Mathivanan,et al.  Exosomes: extracellular organelles important in intercellular communication. , 2010, Journal of proteomics.

[33]  Xiuping Liu,et al.  Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells , 2009, Autophagy.

[34]  C. Théry,et al.  Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.

[35]  G. Cheng,et al.  Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy. , 2015, Advanced drug delivery reviews.

[36]  Rong-min Gu,et al.  Plasma post-operative miR-21 expression in the prognosis of gastric cancers. , 2013, Asian Pacific journal of cancer prevention : APJCP.